A Study of AK0529 in Infants Hospitalized With RSV

Stopped We switched this study design to another study per IEC's recommendations.

Conditions

• Respiratory Syncytial Virus Infections

Interventions

• DRUG: AK0529

Sponsor

Shanghai Ark Biopharmaceutical Co., Ltd.